Mark MacNaughton

Mark joined Biovac as Chief Operations Officer in January 2019. He is an invitee of the Board and a member of the Biovac Executive team.

His mandate is:

  • To establish, sustain and improve domestic capacity in vaccine manufacturing in accordance with Biovac’s policies, industry standards, including current Good Manufacturing Practice (cGMP), and applicable laws.
  • To lead and transition all Operational Units including production, supply chain, engineering and project management into fully commercial and sustainable business functions.
  • To ensure optimal systems, processes and products are in place.

Mark holds a National Higher Diploma in Chemical Engineering and a Master’s Degree in Business Leadership from the University of South Africa.

Mark has over 26 years of operational, design, project and general management experience in a variety of industries. This includes 13 years within the FMCG industry including key roles in process and design engineering, operations and general management. He entered the pharmaceutical industry 13 years ago as the General Manager responsible for the successful start-up and commercialisation of a new small volume parenteral (sterile) facility supplying sterile products worldwide. Further to this he was the Head of Strategic Projects responsible for the design, construction and qualification of a new sterile manufacturing facility in South Africa.